552 related articles for article (PubMed ID: 17574165)
1. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting.
Barlis P; Horrigan M; Elis S; Chan R; Wong M; Farouque O; Proimos G; Ajani AE; Clark DJ
Cardiovasc Revasc Med; 2007; 8(2):84-9. PubMed ID: 17574165
[TBL] [Abstract][Full Text] [Related]
2. Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation disease.
Sheiban I; Gerasimou A; Bollati M; Biondi-Zoccai G; Sciuto F; Omedé P; Sillano D; Trevi GP; Moretti C
Catheter Cardiovasc Interv; 2009 Jan; 73(1):25-31. PubMed ID: 19089932
[TBL] [Abstract][Full Text] [Related]
3. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
Gioia G; Matthai W; Gillin K; Dralle J; Benassi A; Gioia MF; White J
Catheter Cardiovasc Interv; 2007 Jul; 70(1):26-33. PubMed ID: 17585381
[TBL] [Abstract][Full Text] [Related]
4. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
[TBL] [Abstract][Full Text] [Related]
5. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
[TBL] [Abstract][Full Text] [Related]
6. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
[TBL] [Abstract][Full Text] [Related]
7. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis.
White AJ; Kedia G; Mirocha JM; Lee MS; Forrester JS; Morales WC; Dohad S; Kar S; Czer LS; Fontana GP; Trento A; Shah PK; Makkar RR
JACC Cardiovasc Interv; 2008 Jun; 1(3):236-45. PubMed ID: 19463306
[TBL] [Abstract][Full Text] [Related]
8. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
[TBL] [Abstract][Full Text] [Related]
9. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
[TBL] [Abstract][Full Text] [Related]
10. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E
Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580
[TBL] [Abstract][Full Text] [Related]
11. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
JACC Cardiovasc Interv; 2010 Jun; 3(6):612-23. PubMed ID: 20630454
[TBL] [Abstract][Full Text] [Related]
12. Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry.
Carrié D; Eltchaninoff H; Lefèvre T; Silvestri M; Brunel P; Fajadet J; Moynagh A; Gilard M; Koning R; Dibie A; Darremont O; Lablanche JM; Blanchard D;
EuroIntervention; 2011 Oct; 7(6):680-8. PubMed ID: 21986326
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis.
Boudriot E; Thiele H; Walther T; Liebetrau C; Boeckstegers P; Pohl T; Reichart B; Mudra H; Beier F; Gansera B; Neumann FJ; Gick M; Zietak T; Desch S; Schuler G; Mohr FW
J Am Coll Cardiol; 2011 Feb; 57(5):538-45. PubMed ID: 21272743
[TBL] [Abstract][Full Text] [Related]
14. Clinical and angiographic results of angioplasty with a paclitaxel-eluting stent for unprotected left main coronary artery disease (a study of 101 consecutive patients).
Cherradi R; Ouldzein H; Zouaoui W; Elbaz M; Puel J; Carrié D
Arch Cardiovasc Dis; 2008 Jan; 101(1):11-7. PubMed ID: 18391867
[TBL] [Abstract][Full Text] [Related]
15. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
17. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis.
Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Hong MK; Park SW; Park SJ
J Am Coll Cardiol; 2010 Jun; 55(23):2544-52. PubMed ID: 20513593
[TBL] [Abstract][Full Text] [Related]
18. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.
Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR
JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112
[TBL] [Abstract][Full Text] [Related]
19. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease.
Yang JH; Gwon HC; Cho SJ; Hahn JY; Choi JH; Choi SH; Lee YT; Lee SH; Hong KP; Park JE
Ann Thorac Surg; 2008 Jan; 85(1):65-70. PubMed ID: 18154782
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention and drug-eluting stents in patients with unprotected left main coronary artery narrowings.
Lee MS; Yang T; Dhoot J; Liao H
Am J Cardiol; 2010 Apr; 105(8):1070-5. PubMed ID: 20381655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
